COGT · Cogent Biosciences, Inc.

$36.91 +0.68 (+1.88%)

Market Cap

$6.37B

173.52M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-10	—
8-K	2026-08-10	—
10-Q	2026-08-10	2026-06-30
8-K	2026-06-11	2026-06-09
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-05-05	—
10-Q	2026-05-05	2026-03-31
DEF 14A	2026-04-23	2026-06-09
8-K	2026-02-17	—
10-K	2026-02-17	2025-12-31
8-K	2025-12-08	2025-12-06
8-K	2025-11-18	—
8-K	2025-11-13	2025-11-11
8-K	2025-11-10	—
10-Q	2025-11-07	2025-09-30
8-K	2025-11-03	—
8-K	2025-09-11	2025-09-05
8-K	2025-08-05	—
10-Q	2025-08-05	2025-06-30
8-K	2025-07-10	2025-07-07
8-K	2025-07-07	—
8-K	2025-06-11	—
8-K	2025-06-05	2025-06-04
10-Q	2025-05-06	2025-03-31
8-K	2025-05-06	—
DEF 14A	2025-04-22	2025-06-04
10-K	2025-02-25	2024-12-31
8-K	2025-02-25	—
8-K	2024-12-09	2024-12-08
8-K	2024-11-12	—
10-Q	2024-11-12	2024-09-30
8-K	2024-09-03	—
8-K	2024-08-06	—
10-Q	2024-08-06	2024-06-30
8-K	2024-06-27	—
8-K	2024-06-05	—
10-Q	2024-05-07	2024-03-31
8-K	2024-05-07	—
DEF 14A	2024-04-23	2024-06-05
8-K	2024-03-22	2024-03-21
8-K	2024-02-26	—
10-K	2024-02-26	2023-12-31
8-K	2024-02-14	2024-02-13
8-K	2023-12-11	2023-12-09
10-Q	2023-11-07	2023-09-30
8-K	2023-11-02	—
8-K	2023-08-08	—
10-Q	2023-08-08	2023-06-30
8-K	2023-06-08	2023-06-06
8-K	2023-06-07	—

Showing 1–50 of 113 filings

Key facts CIK 1622229 CUSIP 19240Q201 13F (30d) 306 filings 297 filers Visit website Investor relations